5-(2-Chloroethyl)-2'-deoxyuridine
Grundinformationen
- CAS
90301-59-0- Standard-SMILES
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1CCCl- InChIKey
UUSHUCRHZYSZKI-DJLDLDEBSA-N- Summenformel
- C11H15ClN2O5
- Durchschnittliche Molmasse
- 290,7 g/mol
- Monoisotopische Masse
- 290,06694926
Überblick
5-(2-Chloroethyl)-2'-deoxyuridine is a pyrimidine 2'-deoxyribonucleoside.
Namen und Bezeichner
- Bevorzugter Name
- 5-(2-Chloroethyl)-2'-deoxyuridine
- IUPAC
- 5-(2-chloroethyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
- Englischer Name
- 5-(2-chloroethyl)-1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl ]pyrimidine-2,4-dione
- Summenformel
- C11H15ClN2O5
- Molmasse
- 290.7
Namen und Synonyme
5-(2-Chloroethyl)-2'-deoxyuridine90301-59-0H1SZ5QC7QD2'-deoxy-5-(2-chloroethyl)uridineUridine, 5-(2-chloroethyl)-2'-deoxy-DTXSID501034152RefChem:101598DTXCID301518837CEDU5-(2-chloroethyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dioneCCRIS 2828BRN 5976898
Weitere Namen anzeigen
Uridine,5-(2-chloroethyl)-2'-deoxy- (9CI)5-(2-chloroethyl)-1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl ]pyrimidine-2,4-dione
UNII-H1SZ5QC7QDSCHEMBL1627089CHEMBL2079575CHEBI:195580UUSHUCRHZYSZKI-DJLDLDEBSA-N5-(2-CHLOROETHYL)DEOXYURIDINEAKOS030239862"5-(2-chloroethyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
Datenbank-Bezeichner
- CAS
90301-59-0- PubChem CID
- 514814
- DTXSID
DTXSID501034152- ChEMBL
CHEMBL2079575- ChEBI
CHEBI:195580- UNII
- H1SZ5QC7QD
- Nikkaji
- J413.993C
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -0,7
- Polarare Oberfläche (TPSA)
- 99,1 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 19
- Formalladung
- 0
- Komplexität
- 414
Physikochemische Eigenschaften
- Schmelzpunkt
- 161 · 161-164 °C
- Dichte
- 1.485 · 1.485±0.06 g/cm3(Predicted)
- pka
- 9.24 · 9.24±0.10(Predicted)
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Compounds that inhibit cell production of DNA or RNA.
Anbieter1 Anbieter
杭州六可生物科技有限公司+86-571-86912261 19975279805 · [email protected]
Zugehörige Reaktionen
2
Notizen zur Verbindung
Wird geladen…